Pharmacokinetics of intraarterial mitomycin C in hypoxic hepatic infusion with embolization in the treatment of liver metastases

Vascular Pharmacology

Volumn 39, Issue 1-2, 2002, Pages 1-6

  Cerretani, Daniela ^a   Roviello, Franco ^a   Pieraccini, Massimo ^a   Civeli, Letizia ^a   Correale, Pierpaolo ^a   Francini, Guido ^a   Marrelli, Daniele ^a   De Manzoni, Giovanni ^b   Pinto, Enrico ^a   Giorgi, Giorgio ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

Liver metastases; Locoregional therapy; Mitomycin C pharmacokinetics

Indexed keywords

ALANINE AMINOTRANSFERASE; AMYLASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CISPLATIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; FOLIC ACID; MITOMYCIN C; TRIACYLGLYCEROL LIPASE;

ABDOMINAL PAIN; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMYLASE BLOOD LEVEL; AREA UNDER THE CURVE; ARTERY OCCLUSION; ARTICLE; ARTIFICIAL EMBOLISM; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD SAMPLING; BLOOD TOXICITY; CANCER SURGERY; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DRUG ACTIVATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EXPOSURE; DRUG HALF LIFE; DRUG SAFETY; FEMALE; FEVER; HEPATIC ARTERY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIVER METASTASIS; MALE; PANCREATITIS; PRIORITY JOURNAL; SIDE EFFECT; TRIACYLGLYCEROL LIPASE BLOOD LEVEL;

ADULT; AGED; ANOXIA; AREA UNDER CURVE; COLORECTAL NEOPLASMS; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; INFUSIONS, INTRA-ARTERIAL; LEAST-SQUARES ANALYSIS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; MITOMYCIN;

EID: 0344838668     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1537-1891(02)00280-X     Document Type: Article

References (20)

1. Aigner K.R., Gailhofer S. Celiac axis infusion (MMC, CDDP, 5-FU) and aortic stop-flow infusion vs. abdominal hypoxic perfusion (MMC) in UICC stage III/IV pancreatic cancer-48 patients. Reg. Cancer Treat. 6:1993;1-3. (Supplement).
2. Aigner K.R., Kaevel K. Pelvic stop flow infusion (PSI) and hypoxic pelvic perfusion (HPP) with mitomycin and melphalan for recurrent rectal cancer. Reg. Cancer Treat. 1:1994;6-11.
3. Cascinu S., Silva R.R., Labianca R., Barni S., Mattioli R., Martignoni G., Frontini L., Gasparini G., Catalano V., Baldelli A.M., Giuliodori L., Agostinelli R., Catalano G. A phase II study of Tomudex alternated with methotrexate, 5-fluorouracil, leucovorin in first-line chemotherapy of metastatic colorectal cancer. Ann. Oncol. 10:1999;985-987.
4. Chen H.S.G., Gross J.F. Intra-arterial infusion of anticancer drugs: theoretic aspects of drug delivery and review of responses. Cancer Treat. Rep. 64:1980;31-40.
5. Czejka M., Jager W., Scherrnthaner G. Pharmakokinetik und lokale Verfugbarkeit von Mitomycin. Arzneim.-Forsch. Drug Res. 419:1991;260-263.
6. den Hartigh J., McVie J.G., van Oort W.J., Pinedo M.H. Pharmacokinetics of mitomycin C in humans. Cancer Res. 43:1983;5017-5021.
7. Heisterkamp J., van Hillegersberg R., Ijzermans J.N. Interstitial laser coagulation for hepatic tumours. Br. J. Surg. 86:1999;293-304.
8. Hu E., Hollowell S.B. Pharmacokinetics of intra-arterial mitomycin C in humans. Cancer Res. 43:1983;4474-4477.
9. Ichikawa W., Nihei Z., Sawai S. Efficacy of intra-arterial infusion chemotherapy for metastatic liver tumors of the colon cancer. Reg. Cancer Treat. 5:1992;154-158.
10. Kennedy K.A., Rockwell S., Santorelli A.C. Preferential activation of mitomycin C to cytotoxic metabolites by hypoxic tumor cells. Cancer Res. 40:1980;2356-2360.
11. Oldhafer K.J., Frerker M.K., Lang H., Fauler J., Flemming P., Schmoll E., Nadalin S., Moreno L., Pichlmayr R. High-dose mitomycin C in isolated hyperthermic liver perfusion for unresectable liver metastases. J. Invest. Surg. 11:1998;393-400.
12. Paroni R., Arcelloni C., De Vecchi E., Fermo I., Mauri D., Colombo R. Plasma mitomycin C concentrations determined by HPLC coupled to solid-phase extraction. Clin. Chem. 43:1997;615-618.
13. Roversi R., Cavallo G., Ricci S., Rossi G., Roversi M., Fiorentini G. Hypoxic stop-flow liver perfusion: preliminary results in the treatment of multiple hepatic metastases. Radiol. Med. 93:1997;410-417.
14. Rowland M., Thomas N.T. Clinical pharmacokinetics, concepts and application. Williams, Zilkins 3rd ed. 1995;313-322 Williams and Wilkins. Philadelphia.
15. Rump A.F.E., Botvinik-Helling S., Theison M., Biederbick W., Schierholz J.M., Stemmler M., Fischbach R., Heindel W., Lackner K., Klaus W. Pharmacokinetics of intraarterial mitomicyn C in the chemoembolization treatment of liver metastases. Gen. Pharmacol. 27:1996;669-671.
16. Sartorelli C. Therapeutic attack of hypoxic cells of solid tumors:presidential address. Cancer Res. 48:1988;775-778.
17. Solbiati L., Ierace T., Goldberg S.N., Sironi S., Livraghi T., Fiocca R., Servadio G., Rizzatto G., Mueller P.R., Del Maschio A., Gazelle G.S. Percutaneous US-guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients. Radiology. 202:1997;195-203.
18. Wallace S., Carrasco C.H., Charnasagavej C., Richli W.R., Wright K., Gianturco C. Hepatic artery infusion and chemoembolization in the management of liver metastases. Cardiovasc. Interv. Radiol. 13(3):1990;153-160.
19. Wanebo H. A staging system for liver metastasis from colorectal cancer. Proc. Am. Soc. Clin. Oncol. 3:1984;143.
20. Zamparelli G., Pancera G., Pessi M.A., Dallavalle G., Pirovano M., Valsecchi R., Labianca R., Samori G., Luporini G. Locoregional chemotherapy of liver metastasis from colorectal carcinoma. Ann. Ital. Chir. 67:1996;793-797.